Business
WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES
WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES.
About this update from Winvest Group Ltd.
[{"type":"text","content":"\r\n\r\n \r\n \r\n WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES\r\n \r\n \r\n\r\n\r\nWINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\nRENO, Nev., Aug. 22, 2025 /PRNewswire/ -- Winvest Group Limited (OTCQB: WNLV) (\"Winvest\"), an investment holding company with diverse media, entertainment, and technology portfolios, is pleased to announced that its subsidiary IQI Media Inc. has partnered with BioCalth International Inc., a world leader in the development of proprietary health supplements, to help BioCalth grow its direct-to-consumer sales.\r\n\r\n \r\n\r\n The two companies have entered into a content management agreement with profit-sharing incentives that they hope will lead to a long-term relationship marked by increased revenue and brand recognition for BioCalth. The agreement offers IQI Media a fixed monthly retainer as well as a percentage of the profit margin once total net revenue from conversions reaches $30,000 to $1,000,000+.\r\n\"BioCalth has been a prominent player in the supplement industry for over 25 years, manufacturing their patented products here in the USA while exporting them globally through various retailers,\" said Khiow Hui Lim, Founder of IQI Media. \"We're excited to support BioCalth in launching their first ecommerce store and introducing calcium L-threonate—their flagship product backed by three patents—to a new generation of health-conscious consumers.\r\nAs part of the launch, IQI will be working to help BioCalth's products gain traction through a top-of-funnel (TOFU) strategy for social marketing that builds awareness and trust. \"BioCalth has conducted extensive laboratory research at UCLA, scientifically verifying that our calcium L-threonate formula has a 95% absorption rate,\" said Jackson Wen, Founder of BioCalth. \"With the help of IQI, we can get the word out about how our clinically proven product is better absorbed by the body than almost any other calcium supplement.\"\r\nIn addition to kicking off direct-to-consumer sales and social marketing that targets audiences focused on self-care and bone density, BioCalth is also expanding its manufacturing pipeline at its state-of-the-art California plant by providing manufacturing services to others, inclu...